Objectives: To analyse the clinical features of Henoch-Schönlein purpura (HSP) with or without nephritis in Chinese children and to determine the risk factors for renal involvement. Methods: Patient characteristics, clinical parameters and laboratory data were retrospectively analysed in patients with HSP with or without nephritis. Logistic regression analysis was used to identify the risk factors for renal involvement. Results: A total of 535 patients with HSP were included in the study. HSP nephritis occurred in 267 patients (49.9%), ranging from isolated haematuria in 5.2%, mild proteinuria in 77.5%, moderate proteinuria in 6.4% and severe proteinuria in 10.9% of cases. In 90% of the cases, nephritis developed within 1 week of HSP onset; 98.5% of the cases with nephritis developed the condition within 1 month. Risk factors for the development of nephritis were age !6 years, purpura on sites other than the lower limbs and the presence of occult blood in the stool. Conclusion: These results suggest that patients aged !6 years, or who have purpura on the upper limbs or face, or who have occult blood in the stool should be particularly monitored for signs of nephritis.
Introduction
Henoch-Scho¨nlein purpura (HSP) is a common systemic vasculitis syndrome characterized by nonthrombocytopenic purpura, arthritis/arthralgia, abdominal pain, gastrointestinal bleeding and glomerulonephritis. 1 HSP can occur at any age, but is more common in children than in adults. 2 Extrarenal symptoms typically resolve rapidly without complications, and the longterm prognosis of HSP mainly depends on the severity of renal involvement, termed Henoch-Scho¨nlein purpura nephritis (HSPN). 3, 4 Renal manifestations vary from microhaematuria and minimal proteinuria to nephrotic syndrome; the proportion of patients with renal involvement also varies widely, with incidences ranging between 20 and 56% reported in different studies. 5 Although most patients with HSPN experience mild and self-limiting renal disease, 6 up to 20% of children with HSPN will develop chronic kidney disease, with up to 2% progressing to end-stage renal disease. 4, 5, [7] [8] [9] The present study retrospectively evaluated Chinese children with HSP in order to investigate the clinical features of HSP with or without nephritis, to examine the relationship between clinical features and renal manifestations, and to determine the risk factors for developing HSPN.
Patients and methods Patients
Data from all children hospitalized with HSP in the Nephrology and Rheumatology Department, Shanghai Children's Medical Centre, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, between January 2006 and June 2012 were retrospectively analysed. Criteria for inclusion in the study were: a diagnosis of HSP based on the presence of palpable purpura plus at least one of abdominal pain, arthralgia, and haematuria/proteinuria (based on the definitions set out by the European League Against Rheumatism 10 ); first onset of HSP; follow-up for ! 6 months. Written informed consent was obtained from patients' parents and the study protocol was approved by the Ethics Committee of Shanghai Children's Medical Centre.
At the time of diagnosis, standard tests including full blood count analysis of C-reactive protein, serum albumin, cystatin C, immunoglobulins A, G and M, and coagulation biomarkers D-dimer and fibrinogen, were performed. In addition, peripheral blood T-cells, B-cells and natural killer (NK) cells were investigated using flow cytometry with CD3/CD4/CD8, CD19 and CD56 antibodies, respectively. After admission, urinary protein and haematuria were evaluated every 7 days and stools were tested for occult blood to monitor for gastrointestinal bleeding every 3 days. For patients with severe abdominal pain or arthralgia, 1-2 mg/kg methylprednisolone was given for pain relief.
HSPN definition and treatment
Henoch-Scho¨nlein purpura nephritis was defined as the presence of haematuria and/ or proteinuria at two different timepoints within 6 months of HSP onset. Haematuria was defined as >5 red blood cells per highpower microscopic field and proteinuria was defined as >150 mg protein/24 h, according to guidelines set out by the Subspecialty Group of Nephrology of the Chinese Society of Pediatrics. 11 HSPN was divided into four subgroups: isolated haematuria; mild proteinuria ( 25 mg protein/kg per day) plus haematuria; moderate proteinuria (25-50 mg protein/kg per day) plus haematuria; severe proteinuria/nephrotic syndrome (!50 mg protein/kg per day) plus haematuria.
All patients with proteinuria were treated with angiotensin converting enzyme inhibitors. For patients with moderate proteinuria, prednisone was added. If severe proteinuria was detected, a renal biopsy was performed and a therapy regimen based on the histological findings was administered.
Statistical analyses
Results were reported as mean AE SD. Results were compared using the 2 -test for categorical variables and the independent samples t-test for continuous variables. A receiver operating characteristic curve was used to detect cut-off values for differentiating patients with nephritis from those without nephritis. A logistic regression model was used to assess the risk factors for HSPN. A P-value < 0.05 was considered to be statistically significant. All statistical analyses were performed using SPSS Õ software version 16.0 (SPSS Inc., Chicago, IL, USA).
Results

Patient characteristics
A total of 535 patients with HSP were enrolled in the study: 308 were male; 227 were female. The mean age of onset of HSP was 6.9 AE 2.7 years (range of 2-16 years) but most cases occurred in those aged 4-11 years. Patient characteristics are given in Table 1 . Of the 267 with renal involvement, 90% developed nephritis within 1 week of HSP onset and 98.5% developed nephritis within 1 month of HSP onset.
Risk factors for developing HSPN
Clinical features were compared in patients with or without nephritis ( Table 2 ). There was no sex-related between-group difference, but patients with nephritis were significantly older than those without nephritis (P < 0.001). There were no significant differences in the incidence of arthralgia and abdominal pain between patients with or without neprhitis. All patients had purpura on the lower limbs, but additional purpura on other sites (e.g. upper limbs, face or neck) occurred more frequently in patients with nephritis than in those without nephritis (P ¼ 0.002). Bloody stools were seen more often in patients with nephritis than in those without (P ¼ 0.007). In addition, significantly more patients with nephritis were positive for occult blood in their stools than patients without nephritis (P ¼ 0.001).
There were no significant differences in white blood cell count, platelet count, mean platelet volume or C-reactive protein level between HSP patients with or without nephritis. The percentage of neutrophils was higher in patients with nephritis than those without nephritis (P ¼ 0.009). In addition, levels of albumin were lower (P ¼ 0.013), and cystatin C (P ¼ 0.016) higher, in patients with nephritis than in patients without nephritis. No significant differences were seen in D-dimer or fibrinogen levels ( Table 2 ).
There were no significant differences between the two groups in T-cell, B-cell or NK-cell percentages or ratios, or in levels of serum immunoglobulin A, M or G ( Table 2) . Parameters that showed a significant difference between the two groups were analysed by logistic regression analysis to determine the risk factors for nephritis in HSP. As the numbers of patients with occult blood were higher than those with bloody stools, the presence of occult blood in the stool was selected to represent gastrointestinal involvement. For continuous parameters, receiver operating characteristic curves were used to find the cut-off values for differentiating patients with nephritis from those without nephritis. Cut-off values for age, albumin and cystatin C were !6 years, 36 g/l and 0.61 mg/l, respectively. Univariate analysis showed that age !6 years, purpura on sites other than the lower limbs, presence of occult blood in the stool and a cystatin C level !0.61 mg/l were associated with HSPN (Table 3 ). Multivariate analysis showed that age !6 years (P < 0.001), purpura on sites other than the lower limbs (P ¼ 0.013) and the presence of occult blood in the stool (P ¼ 0.001) were independent risk factors for the development of renal involvement (Table 3 ).
Discussion
The present study retrospectively analysed clinical features and renal manifestations in 535 patients with HSP. Of these, 267 patients (49.9%) had nephritis, ranging in severity from isolated haematuria to nephrotic proteinuria. Age !6 years, purpura on sites other than the lower limbs and the presence of occult blood in the stool were shown to be risk factors for developing HSPN. To our knowledge, this is the largest recent survey of this disease in China. Studies have reported an incidence of nephritis of 20-54% in patients with HSP. 4 In the present study, 49.9% of patients had renal involvement. Most patients (90%) with renal involvement developed nephritis within 1 week of HSP onset, with 98.5% developing nephritis within 1 month and only 1.5% developing nephritis between 1 and 6 months of disease onset.
Consistent with previous reports, [12] [13] [14] in the present study a greater age and the presence of occult blood in the stool were positively correlated with the development of nephritis. Clinically, purpura on the lower limbs occurred in all patients with HSP, but a small percentage also had purpura on the face, neck or upper limbs, and this was an independent risk factor for nephritis. Another study reported that persistent purpura was a risk factor for nephritis in HSP. 14 To our knowledge, the present study is the first to focus on the significance of purpura distribution in a large cohort analysis.
The pathogenetic mechanisms leading to HSPN have not yet been clearly delineated, but cellular and humoral immune dysfunction may be involved in the development of nephritis. 15 In the present study, T-cell, B-cell and NK cell percentages and ratios in peripheral blood and serum concentrations of immunoglobulins A, M and G were measured, but no significant differences were found between HSP patients with or without nephritis. However, immune function was only tested at one timepoint; dynamic monitoring may be required to clarify the roles of the cellular and humoral immune systems in HSPN pathogenesis.
Most patients with HSPN will regain normal renal function; however, a small percentage will progress to chronic kidney disease, or even to end-stage renal disease after 20 years or longer. 16 Edstro¨m Halling et al. 17 reported that severe symptoms with nephritic or nephrotic syndrome correlated with poor outcomes. In the present study, 17.3% of patients had moderate or severe proteinuria, but the follow-up period was too short to report on prognosis.
The present study has the limitations of being a retrospective study, in which the HSP diagnosis was based on clinical symptoms without skin biopsies. However, the study included a large number of consecutive patients and could provide useful information regarding the risk factors for the development of HSPN.
In conclusion, the present study showed that age !6 years, purpura on sites other than the lower limbs and the presence of occult blood in the stool were independent risk factors for developing HSPN in a Chinese population. Most patients with HSPN developed nephritis within 1 month after HSP onset. These results suggest that patients aged !6 years, or who have purpura on the upper limbs or face, or who have occult blood in the stool should be monitored specifically for signs of nephritis.
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